Pan-cancer landscape of epigenetic factor expression predicts tumor outcome

被引:7
|
作者
Cheng, Michael W. [1 ]
Mitra, Mithun [2 ,3 ]
Coller, Hilary A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA
关键词
DNA METHYLATION; CHROMATIN; EPIGENOME; ENVIRONMENT; MECHANISMS; REGULATORS; HALLMARKS; PATTERNS; GENETICS; THERAPY;
D O I
10.1038/s42003-023-05459-w
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oncogenic pathways that drive cancer progression reflect both genetic changes and epigenetic regulation. Here we stratified primary tumors from each of 24 TCGA adult cancer types based on the gene expression patterns of epigenetic factors (epifactors). The tumors for five cancer types (ACC, KIRC, LGG, LIHC, and LUAD) separated into two robust clusters that were better than grade or epithelial-to-mesenchymal transition in predicting clinical outcomes. The majority of epifactors that drove the clustering were also individually prognostic. A pan-cancer machine learning model deploying epifactor expression data for these five cancer types successfully separated the patients into poor and better outcome groups. Single-cell analysis of adult and pediatric tumors revealed that expression patterns associated with poor or worse outcomes were present in individual cells within tumors. Our study provides an epigenetic map of cancer types and lays a foundation for discovering pan-cancer targetable epifactors. A pan-cancer machine learning model using epifactor expression data for five cancer types and single-cell analysis of adult and pediatric tumors reveal expression patterns associated with poor or worse outcomes are present in individual cells within tumors.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure
    Ziying Lin
    Lixia Huang
    ShaoLi Li
    Jincui Gu
    Xiaoxian Cui
    Yanbin Zhou
    Scientific Reports, 10
  • [42] Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure
    Lin, Ziying
    Huang, Lixia
    Li, ShaoLi
    Gu, Jincui
    Cui, Xiaoxian
    Zhou, Yanbin
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] A pan-cancer landscape of pathogenic somatic copy number variations
    Becchi, Tommaso
    Beltrame, Luca
    Mannarino, Laura
    Calura, Enrica
    Marchini, Sergio
    Romualdi, Chiara
    JOURNAL OF BIOMEDICAL INFORMATICS, 2023, 147
  • [44] PUREE: accurate pan-cancer tumor purity estimation from gene expression data
    Egor Revkov
    Tanmay Kulshrestha
    Ken Wing-Kin Sung
    Anders Jacobsen Skanderup
    Communications Biology, 6
  • [45] The pan-cancer landscape presented ITGA7 as a prognostic determinant, tumor suppressor, and oncogene in multiple tumor types
    Zarei, Mahboobeh
    Sadri, Fatemeh
    Khorasani, Amirhossein Mohajeri
    Mirinezhad, Mohammadreza
    Mousavi, Pegah
    FASEB JOURNAL, 2024, 38 (19):
  • [46] Pan-cancer characterization of tumor immune microenvironment.
    Chu, Tianqing
    Bei, Zhang
    CANCER RESEARCH, 2021, 81 (13)
  • [47] Comparing of pan-cancer tumor immune microenvironment.
    Ye, Jiaan
    Cui, Longgang
    Zhao, Xiaochen
    Lan, Guanghui
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations
    Dong, Hongxiu
    Zhou, Shijie
    Chen, Xuxi
    Deng, Xuejie
    Fang, Aiping
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (02) : 225 - 236
  • [49] PGDx Expands Pan-Cancer Tumor Profiling Offerings
    1600, Mary Ann Liebert Inc. (37):
  • [50] A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment
    Shao, Wei
    Zhao, Hui
    Zhang, Shoudu
    Ding, Qian
    Guo, Yugang
    Hou, Kaiqi
    Kan, Yunchao
    Deng, Fan
    Xu, Qian
    FRONTIERS IN ONCOLOGY, 2023, 12